WuXi Bio eyes top end price for $510m HK float
WuXi Biologics is set to price its HK$3.9bn ($510.4m) IPO at the top of expectations following a blockbuster response from investors.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: